These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19963078)

  • 1. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M; Sheen P; Quiliano M; Gutierrez A; Gilman RH
    Infect Genet Evol; 2010 Mar; 10(2):346-9. PubMed ID: 19963078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
    Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
    Zhang H; Bi LJ; Li CY; Sun ZG; Deng JY; Zhang XE
    J Int Med Res; 2009; 37(5):1430-5. PubMed ID: 19930847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
    Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
    mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
    Yoon JH; Nam JS; Kim KJ; Ro YT
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2821-8. PubMed ID: 25034468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3672-3. PubMed ID: 14576145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Mestdagh M; Fonteyne PA; Realini L; Rossau R; Jannes G; Mijs W; De Smet KA; Portaels F; Van den Eeckhout E
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2317-9. PubMed ID: 10471589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Aono A; Chikamatsu K; Yamada H; Kato T; Mitarai S
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4928-30. PubMed ID: 24867972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Ferrer P; Gilman RH; López-Llano J; Fuentes P; Valencia E; Zimic MJ
    Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.
    Lemaitre N; Sougakoff W; Truffot-Pernot C; Jarlier V
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1761-3. PubMed ID: 10390238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
    Barco P; Cardoso RF; Hirata RD; Leite CQ; Pandolfi JR; Sato DN; Shikama ML; de Melo FF; Mamizuka EM; Campanerut PA; Hirata MH
    J Antimicrob Chemother; 2006 Nov; 58(5):930-5. PubMed ID: 16971417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C; Yamane N; Yogesh B; Ano H; Takashima T
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):111-6. PubMed ID: 14972380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.
    Sreevatsan S; Pan X; Zhang Y; Kreiswirth BN; Musser JM
    Antimicrob Agents Chemother; 1997 Mar; 41(3):636-40. PubMed ID: 9056006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
    Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E
    Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.
    Muthaiah M; Jagadeesan S; Ayalusamy N; Sreenivasan M; Prabhu SS; Muthuraj U; Senthilkumar K; Veerappan S
    Int J Mol Sci; 2010 Jul; 11(7):2670-80. PubMed ID: 20717529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.